Trial · NCT05315557
Registered outcomes31
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 31
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Improvement in systemic hemodynamics at 6 hours after randomization | 6 hours after randomization | Improvement in systemic hemodynamics defined as discontinuation of noradrenaline infusion OR reversal of shock |
| Secondary | Reduction in dose of noradrenaline at the end of 6 hours | 6 hours | |
| Secondary | Amount of noradrenaline requirements between in each arm at the end of 6 hours | 6 hours | |
| Secondary | Improvement in Systemic Vascular Resistance (SVR) by 10% or above 500 at 6 hours | 6 hours | Systemic Vascular Resistance will be measured by using pulmonary thermodilution |
| Secondary | Improvement in SVR by 10% or above 500 at 12 hours | 12 hours | |
| Secondary | Improvement in SVR by 10% or above 500 at 48 hours | 48 hours | |
| Secondary | Decrease in Cardiac output by 10% or less than 6L after 6 hours of randomization | 6 hour of randomization | Cardiac output will be measured by using pulmonary thermodilution |
| Secondary | KDIGO criteria - increase in urine output in 6 hours | 6 hour | |
| Secondary | KDIGO criteria - increase in urine output in 12 hours. | 12 hour | |
| Secondary | KDIGO criteria - increase in urine output in 24 hours | 24 hour | |
| Secondary | KDIGO criteria - increase in urine output in 48 hours. | 48 hour | |
| Secondary | improvement in serum creatinine in 24 (Improvement in KDIGO stage at 24) | 24 hour | |
| Secondary | Improvement in serum creatinine in 48 hours (Improvement in KDIGO stage at 48 hours) | 48 hour | |
| Secondary | Need of Renal Replacement Therapy | Day 28 | |
| Secondary | Improvement in microcirculation as measured by improvement in lactate | 6 hours | |
| Secondary | Improvement in microcirculation as measured by improvement in capillary refill time at 6 hours | 6 hours | |
| Secondary | Improvement in microcirculation as measured by Near IR spectroscopy ina subset of patients whenever feasible | 6 hours | |
| Secondary | Improvement in microcirculation as measured by improvement in lactate | 24 hours | |
| Secondary | Improvement in microcirculation as measured by improvement in capillary refill time at 24 hours. | 24 hours | |
| Secondary | Improvement in microcirculation as measured by Near IR spectroscopy ina subset of patients whenever feasible | 24 hours |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05315557/registered